Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia

Despite major advances in the management and high cure rates of childhood acute lymphoblastic leukemia (ALL), patients still suffer from many drug-induced toxicities, sometimes necessitating dose reduction, or halting of cytotoxic drugs with a secondary risk of disease relapse. In addition, investig...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmgenomics Pers Med
Asıl Yazarlar: Maamari, Dimitri, El-Khoury, Habib, Saifi, Omran, Muwakkit, Samar A, Zgheib, Nathalie K
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2020
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7429230/
https://ncbi.nlm.nih.gov/pubmed/32848445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S239602
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller